Data & Analytics

A new global consortium aims to break the antibiotic R&D logjam, using open science and AI to combat the growing superbug crisis threatening millions.

India's 'Vaccine Capital' unveils a bold new policy at Davos, shifting from manufacturing to high-value innovation to join the world's top life sciences hubs.

A new partnership promises up to 22% savings for employers by integrating deep pharmacy expertise, tackling one of healthcare's most complex challenges.

A breakthrough liquid biopsy using '6-base genome' analysis shows unprecedented success in spotting Stage I colorectal cancer, promising to boost survival rates.

A new AI-driven platform from CAS aims to democratize complex IP research, making high-stakes patent analysis accessible to entire organizations.

Canadian giant Aurora Cannabis gains exclusive EU rights for two key strains, signaling a new era of genetic ownership in Europe's booming medical market.

As AI and data centers drive electricity demand to unprecedented levels, geoscientists are looking deep underground for the power of the future.

The nation attracted 67 advanced FDI projects in 2025, but emerging signs of a slowdown and global competition test its long-term competitiveness.

Spanish tech giant Indra wins a landmark contract to modernize London's transit ticketing, promising a smarter, more seamless commute for millions.

Vaximm appoints Sébastien Wieckowski as CSO, leveraging his data science expertise to advance its oral cancer vaccine platform at a pivotal clinical stage.

Data center firm EdgeMode alleges a "pay-to-play" scheme after a negative report, detailing its innovative energy strategy to bypass grid constraints for AI.

With its new non-control fund oversubscribed, New Mountain Capital is doubling down on its strategy of investing in resilient, acyclical industries.

Merck's former R&D IT head Matt Studney joins TetraScience, a move highlighting biopharma's critical pivot from fragmented data to industrial-scale AI.

A new alliance in healthcare marketing merges pharmaceutical expertise with provider-side insights, leveraging AI and big data to fix a fragmented system.

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

With three new executive appointments, Armada signals an aggressive new strategy under CEO Chris O'Brien to unify its brand and accelerate growth.

Morrison Healthcare wins a top award for revolutionizing hospital dining with climate-friendly menus, data-driven waste reduction, and planet-healthy choices.

WindRose and Francisco Partners invest in Avalon, signaling a major shift toward tech-driven management of the multi-billion dollar diagnostic testing market.

The Midwestern 'Modern General Store' earns top national honors for its website and in-store service, revealing a powerful hybrid retail strategy.

A new collaboration between the Global Alzheimer's Platform and Alamar Biosciences aims to revolutionize diagnosis with ultra-sensitive blood tests for all.